Article

Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine…

medRxiv · 2023 · Bowe, M. L.; Wright, E. M.; Pushko, P.; Backstedt, B.; Gardner, C.; Short-Freeman, M.; Kar, S.; Wright, D. C.

Key facts

Title Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine containing modified S1 spike protein of SARS-CoV-2 variant C.1.2
First author Bowe, M. L.; Wright, E. M.; Pushko, P.; Backstedt, B.; Gardner, C.; Short-Freeman, M.; Kar, S.; Wright, D. C.
Journal medRxiv
Published Sep 5, 2023
DOI 10.1101/2023.08.31.555805
Devices mentioned K073487, K073489, K073490
Product codes mentioned CFN, JCJ, JJH, JIS

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature